Novartis finds no evidence of wrongdoing in clinical trials

Singapore: Novartis Pharma KK has found no evidence that data on clinical trials for its hypertension drug Diovan had be...

July 31, 2013 | Wednesday | News
BI, Lilly's diabetes drug Linagliptin shows efficacy

Singapore: Boehringer Ingelheim and Eli Lilly's investigational Type 2 Diabetes (T2D) drug dipeptidyl peptidase-4 (DPP-4...

August 16, 2013 | Friday | News
Actavis 'pregnancy preventer' gets FDA nod

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch ...

May 17, 2013 | Friday | News
Aussie firm Phosphagenics raises $11.45 mn

Singapore: Australian drug delivery company, Phosphagenics, has raised $11.45 million of its $15.29 million capital rais...

July 22, 2014 | Tuesday | News
Patrys gets nod to progress myeloma trial

Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/I...

January 14, 2013 | Monday | News
Eisai seeks approval for antiepileptic agent in Japan

Singapore: Eisai has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare (M...

August 31, 2012 | Friday | Regulatory
Bayer progresses on APAC hepatocellular carcinoma trial

Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with s...

June 11, 2013 | Tuesday | News
Cipla malaria drug gets WHO pre-qualification

Mumbai: Cipla along with the non-profit R&D organization, Drugs for Neglected Diseases initiative (DNDi), revealed t...

October 4, 2012 | Thursday | News
Boston Strategics gets rights for Eisai's cancer drug

Singapore: Boston Strategics Corp (BSC), a clinical-stage drug research and development (R&D) company has signed an ...

July 10, 2014 | Thursday | News
Activation of mTorc1 causes colon, gastric cancers

Singapore: Associate Professor Matthias Ernst and colleagues from Australia's Walter and Eliza Hall Institute have ident...

January 22, 2013 | Tuesday | News
ASLAN announces global license agreement with Almirall

Singapore: ASLAN Pharmaceuticals has obtained the global rights to Almirall's DHODH inhibitor, LAS186323, currently in p...

May 21, 2012 | Monday | News
Ian Frazer gets $200k to make HPV DNA vaccine

Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's N...

December 20, 2012 | Thursday | News
South Korea firm emerges as R&D force

According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...

April 12, 2012 | Thursday | News
FDA offers guidance on Alzheimer's drug development

Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatme...

February 8, 2013 | Friday | News
Zydus initiates Ph III trial of Lipaglyn for lipodystrophy

Singapore: India based drug company, Zydus, has initiated Phase III trials of Lipaglyn (Saroglitazar) to evaluate its sa...

June 2, 2014 | Monday | News
Australian firm gets rights to Anamorelin

Singapore: Melbourne-based biopharmaceutical company Specialised Therapeutics Australia (STA) has been granted exclusive...

October 15, 2012 | Monday | News
3SBio acquires patents for kidney failure drug

Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, ac...

October 31, 2013 | Thursday | News
Glenmark's MAb drug enters human trials

Singapore: Glenmark Pharmaceuticals, a research-driven, global integrated pharmaceutical company announced that its nove...

July 4, 2014 | Friday | News
Avantor launches polysorbates for pharma

Singapore: US-based Avantor Performance Materials has introduced a higher purity Super Refined grade of polysorbate prod...

September 11, 2013 | Wednesday | News
Novartis pledges to eliminate leprosy

Singapore: Novartis Foundation for Sustainable Development (NFSD) has launched a new leprosy strategy focused on interru...

December 2, 2013 | Monday | News
AstraZeneca begins cancer research in Russia

Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed...

February 15, 2013 | Friday | News
Tachycardia holds room to grow: Report

Singapore: A rapid heart rate is a common condition among elderly individuals, and represents a potential goldmine for p...

August 3, 2012 | Friday | Analysis
ETC, AstraZeneca form drug R&D partnership

Singapore: Experimental Therapeutics Center (ETC) and Exploit Technologies of Agency for Science, Technology and Researc...

November 5, 2013 | Tuesday | News
FDA approves Gilead's Stribild

Singapore: The US Food and Drug Administration (FDA) has approved Stribild, a complete once-daily single tablet regimen ...

August 28, 2012 | Tuesday | Regulatory
BNC105 effective in treating cancer

Singapore: Bionomics is going to present clinical trial data from its ongoing US trial of BNC105 in patients with metast...

June 1, 2012 | Friday | News